Home / Business and Economy / Natco Pharma Profit Plummets 34% in Q4

Natco Pharma Profit Plummets 34% in Q4

29 May

Summary

Consolidated net profit declined 34.11% YoY to Rs 267.9 crore in Q4 FY26.
Revenue from operations fell 39.46% YoY to Rs 739.1 crore in the March quarter.
Pharmaceuticals business revenue dropped 40.58%, while agrochemicals saw a 50.66% increase.

Natco Pharma reported a substantial 34.11% year-on-year decrease in consolidated net profit for the fourth quarter of the fiscal year 2026. The company's net profit for the quarter ended March 31, 2026, stood at Rs 267.9 crore, down from Rs 406.6 crore in the same period last year. Revenue from operations also experienced a significant drop, falling by 39.46% to Rs 739.1 crore.

The company's pharmaceuticals business segment recorded a revenue of Rs 716.5 crore, marking a 40.58% decline compared to the previous year. Conversely, the agrochemicals segment demonstrated strong growth, with revenue increasing by 50.66% year-on-year to reach Rs 716.5 crore in Q4 FY26. For the entire fiscal year 2026, Natco Pharma's consolidated net profit declined by 24.76% to Rs 1,418.5 crore.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.